Sustainability & Climate

A renewed partnership extends into a third decade, leveraging advanced logistics to build the Royal Navy's new Type 26 frigates and validating a key acquisition.

The UK-based firm's STIMULAN® is now the only EU-certified calcium matrix for combined antibiotic use, revolutionizing bone infection treatment.

The South Korean tobacco giant hits record revenue as its international strategy pays off, while it diversifies into nicotine pouches for future growth.

Futures designer Nick Foster joins Unlikely Collaborators to challenge prediction, urging us to examine the hidden biases that shape what we see as possible.

Canfor Pulp and Canfor Corp prepare for a critical joint earnings call on March 6 after a year of steep losses and severe market headwinds.

Two industry titans are tackling a major pain point for millions, aiming to make eye makeup safe and comfortable for all contact lens wearers.

The global Japanese chain is targeting the family market with its first kids menu, prioritizing safety and flavor to cultivate a new generation of diners.

With its lead drug MOLBREEVI under FDA review, Savara's upcoming investor talks are a critical test of its path from clinical trials to market.

iVeena promotes key execs as it prepares for clinical trials of a novel eye drop that could reshape pediatric myopia treatment worldwide.

A simple nasal spray could offer immediate, broad protection against the flu. New landmark studies show how this antibody-based shield could revolutionize prevention.

ExxonMobil acquires a key production vessel in a major strategic shift, while SBM Offshore deleverages in a deal reshaping offshore energy partnerships.

Henkel's blockbuster acquisition of Stahl Group reshapes the specialty chemicals market, triggering a profitable, mandatory exit for minority shareholder Clariant.

Moxe Health's inaugural Best in KLAS award reveals a new standard for trust and efficiency in breaking down data silos between payers and providers.

Global construction costs are climbing, but a new report warns that unpredictable market volatility, not inflation, is the true threat to project delivery.

Cincinnati's Timber Bay Partners oversubscribes its fund, proving investor appetite for specialized strategies in the booming GP-led secondary market.

After a record year in the U.S., Mauna Kea Technologies unveils a new international strategy and leadership model to scale its diagnostic platforms globally.

FASHION by Informa unveils its 2026 Incubator class, a strategic program providing vital market access and mentorship to combat systemic industry inequality.

Toray's next-gen material has achieved a key certification, promising to slash costs and accelerate the development of future aircraft and defense systems.

A breakthrough program at Children's Hospital of Philadelphia is redefining heart pumps as tools for recovery, not just a bridge to transplant.

A new report reveals AI's efficiency promise is a myth, as marketers lose hours to fact-checking and over a third publish inaccurate AI content.